{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:08:50Z","timestamp":1794262130085,"version":"4.9.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Which isoforms of apolipoprotein E (apoE) we inherit determine our risk of developing late-onset Alzheimer\u2019s Disease (AD), but the mechanism underlying this link is poorly understood. In particular, the relevance of direct interactions between apoE and amyloid-\u03b2 (A\u03b2) remains controversial. Here, single-molecule imaging shows that all isoforms of apoE associate with A\u03b2 in the early stages of aggregation and then fall away as fibrillation happens. ApoE-A\u03b2 co-aggregates account for ~50% of the mass of diffusible A\u03b2 aggregates detected in the frontal cortices of homozygotes with the higher-risk\n                    <jats:italic>APOE4<\/jats:italic>\n                    gene. We show how dynamic interactions between apoE and A\u03b2 tune disease-related functions of A\u03b2 aggregates throughout the course of aggregation. Our results connect inherited\n                    <jats:italic>APOE<\/jats:italic>\n                    genotype with the risk of developing AD by demonstrating how, in an isoform- and lipidation-specific way, apoE modulates the aggregation, clearance and toxicity of A\u03b2. Selectively removing non-lipidated apoE4-A\u03b2 co-aggregates enhances clearance of toxic A\u03b2 by glial cells, and reduces secretion of inflammatory markers and membrane damage, demonstrating a clear path to AD therapeutics.\n                  <\/jats:p>","DOI":"10.1038\/s41467-024-49028-z","type":"journal-article","created":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T14:01:36Z","timestamp":1717250496000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Co-aggregation with Apolipoprotein E modulates the function of Amyloid-\u03b2 in Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5977-9691","authenticated-orcid":false,"given":"Zengjie","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily E.","family":"Prescott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Urbanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hollie E.","family":"Wareing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne C.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Olerinyova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0571-5892","authenticated-orcid":false,"given":"Helen","family":"Dakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Leah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy A.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyna M.","family":"Matuszyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4885-135X","authenticated-orcid":false,"given":"Eleni","family":"Dimou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4777-5239","authenticated-orcid":false,"given":"Eric","family":"Hidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu P.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7408-2342","authenticated-orcid":false,"given":"Jeff Y. L.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S. H.","family":"Danial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3899-5651","authenticated-orcid":false,"given":"Michael R.","family":"Strickland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7791-1396","authenticated-orcid":false,"given":"Damian C.","family":"Crowther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4674-6484","authenticated-orcid":false,"given":"Sohvi","family":"Ohtonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2194-2510","authenticated-orcid":false,"given":"Mireia","family":"G\u00f3mez-Budia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon M.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9118-5714","authenticated-orcid":false,"given":"Laura","family":"Ferraiuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6439-0579","authenticated-orcid":false,"given":"Heather","family":"Mortiboys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Higginbottom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Wharton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3400-0856","authenticated-orcid":false,"given":"David M.","family":"Holtzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9530-7472","authenticated-orcid":false,"given":"Tarja","family":"Malm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan T.","family":"Ranasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7116-6954","authenticated-orcid":false,"given":"David","family":"Klenerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1675-0773","authenticated-orcid":false,"given":"Suman","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,1]]},"reference":[{"key":"49028_CR1","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"CC Liu","year":"2013","unstructured":"Liu, C. C., Takahisa, Xu, H. & Bu, G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat. Rev. Neurol. 9, 106\u2013118 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"49028_CR2","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/mp.2013.194","volume":"19","author":"C Conejero-Goldberg","year":"2014","unstructured":"Conejero-Goldberg, C. et al. APOE2 enhances neuroprotection against Alzheimer\u2019s disease through multiple molecular mechanisms. Mol. Psychiatry 19, 1243\u20131250 (2014).","journal-title":"Mol. Psychiatry"},{"key":"49028_CR3","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder, E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science. 261, 921\u2013923 (1993).","journal-title":"Science."},{"key":"49028_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1474-4422(10)70325-2","volume":"10","author":"PB Verghese","year":"2011","unstructured":"Verghese, P. B., Castellano, J. M. & Holtzman, D. M. Apolipoprotein E in Alzheimer\u2019s disease and other neurological disorders. Lancet Neurol. 10, 241\u2013252 (2011).","journal-title":"Lancet Neurol."},{"key":"49028_CR5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","volume":"17","author":"A-C Raulin","year":"2022","unstructured":"Raulin, A.-C. et al. ApoE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies. Mol. Neurodegener. 17, 72 (2022).","journal-title":"Mol. Neurodegener."},{"key":"49028_CR6","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","volume":"81","author":"T Kanekiyo","year":"2014","unstructured":"Kanekiyo, T., Xu, H. & Bu, G. ApoE and A\u03b2; in Alzheimer\u2019s Disease: Accidental Encounters or Partners? Neuron 81, 740\u2013754 (2014).","journal-title":"Neuron"},{"key":"49028_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy, J. & Selkoe, D. J. The Amyloid Hypothesis of Alzheimer\u2019s Disease: Progress and Problems on the Road to Therapeutics. Science. 297, 353\u2013356 (2002).","journal-title":"Science."},{"key":"49028_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nn.3028","volume":"15","author":"I Benilova","year":"2012","unstructured":"Benilova, I., Karran, E. & De Strooper, B. The toxic A\u03b2 oligomer and Alzheimer\u2019s disease: an emperor in need of clothes. Nat. Neurosci. 15, 349\u2013357 (2012).","journal-title":"Nat. Neurosci."},{"key":"49028_CR9","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.neuron.2009.05.012","volume":"62","author":"S Li","year":"2009","unstructured":"Li, S. et al. Soluble oligomers of amyloid \u03b2 protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 62, 788\u2013801 (2009).","journal-title":"Neuron"},{"key":"49028_CR10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/34910","volume":"391","author":"B De Strooper","year":"1998","unstructured":"De Strooper, B. et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391, 387\u2013390 (1998).","journal-title":"Nature"},{"key":"49028_CR11","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","volume":"82","author":"CL Masters","year":"1985","unstructured":"Masters, C. L. et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl Acad. Sci. 82, 4245\u20134249 (1985).","journal-title":"Proc. Natl Acad. Sci."},{"key":"49028_CR12","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nature13800","volume":"515","author":"SH Choi","year":"2014","unstructured":"Choi, S. H. et al. A three-dimensional human neural cell culture model of Alzheimer\u2019s disease. Nature 515, 274\u2013278 (2014).","journal-title":"Nature"},{"key":"49028_CR13","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1212\/WNL.0000000000003234","volume":"87","author":"J Gonneaud","year":"2016","unstructured":"Gonneaud, J. et al. Relative effect of APO \u03b54 on neuroimaging biomarker changes across the lifespan. Neurology 87, 1696\u20131703 (2016).","journal-title":"Neurology"},{"key":"49028_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2012.04.017","volume":"34","author":"AS Fleisher","year":"2013","unstructured":"Fleisher, A. S. et al. Apolipoprotein E \u03b54 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease. Neurobiol. Aging 34, 1\u201312 (2013).","journal-title":"Neurobiol. Aging"},{"key":"49028_CR15","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.neuron.2017.11.013","volume":"96","author":"C-C Liu","year":"2017","unstructured":"Liu, C.-C. et al. ApoE4 Accelerates Early Seeding of Amyloid Pathology. Neuron 96, 1024\u20131032.e3 (2017).","journal-title":"Neuron"},{"key":"49028_CR16","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1172\/JCI96429","volume":"128","author":"F Liao","year":"2018","unstructured":"Liao, F. et al. Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation. J. Clin. Invest. 128, 2144\u20132155 (2018).","journal-title":"J. Clin. Invest."},{"key":"49028_CR17","doi-asserted-by":"publisher","first-page":"40987","DOI":"10.1074\/jbc.M407963200","volume":"279","author":"SE Wahrle","year":"2004","unstructured":"Wahrle, S. E. et al. ABCA1 Is Required for Normal Central Nervous System ApoE Levels and for Lipidation of Astrocyte-secreted apoE*. J. Biol. Chem. 279, 40987\u201340993 (2004).","journal-title":"J. Biol. Chem."},{"key":"49028_CR18","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3233\/JAD-160467","volume":"54","author":"A Boehm-Cagan","year":"2016","unstructured":"Boehm-Cagan, A. et al. ABCA1 Agonist Reverses the ApoE4-Driven Cognitive and Brain Pathologies. J. Alzheimer\u2019s Dis. 54, 1219\u20131233 (2016).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"49028_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40438-4","volume":"9","author":"A Mouchard","year":"2019","unstructured":"Mouchard, A. et al. ApoE-fragment\/A\u03b2 heteromers in the brain of patients with Alzheimer\u2019s disease. Sci. Rep. 9, 3989 (2019).","journal-title":"Sci. Rep."},{"key":"49028_CR20","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1212\/WNL.0000000000000431","volume":"82","author":"EC Mormino","year":"2014","unstructured":"Mormino, E. C. et al. Amyloid and APOE \u03b54 interact to influence short-term decline in preclinical Alzheimer disease. Neurology 82, 1760\u20131767 (2014).","journal-title":"Neurology"},{"key":"49028_CR21","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/mp.2014.123","volume":"20","author":"YY Lim","year":"2015","unstructured":"Lim, Y. Y. et al. APOE and BDNF polymorphisms moderate amyloid \u03b2-related cognitive decline in preclinical Alzheimer\u2019s disease. Mol. Psychiatry 20, 1322\u20131328 (2015).","journal-title":"Mol. Psychiatry"},{"key":"49028_CR22","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1212\/WNL.0b013e31824365ab","volume":"78","author":"K Kantarci","year":"2012","unstructured":"Kantarci, K. et al. APOE modifies the association between A\u03b2 load and cognition in cognitively normal older adults. Neurology 78, 232\u2013240 (2012).","journal-title":"Neurology"},{"key":"49028_CR23","doi-asserted-by":"publisher","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","volume":"3","author":"JM Castellano","year":"2011","unstructured":"Castellano, J. M. et al. Human apoE Isoforms Differentially Regulate Brain Amyloid-\u03b2 Peptide Clearance. Sci. Transl. Med. 3, 89ra57 (2011).","journal-title":"Sci. Transl. Med."},{"key":"49028_CR24","doi-asserted-by":"publisher","first-page":"eabd7522","DOI":"10.1126\/scitranslmed.abd7522","volume":"13","author":"M Xiong","year":"2021","unstructured":"Xiong, M. et al. APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function. Sci. Transl. Med. 13, eabd7522 (2021).","journal-title":"Sci. Transl. Med."},{"key":"49028_CR25","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0896-6273(95)90079-9","volume":"15","author":"J N\u00e4slund","year":"1995","unstructured":"N\u00e4slund, J. et al. Characterization of stable complexes involving apolipoprotein E and the amyloid \u03b2 peptide in Alzheimer\u2019s disease brain. Neuron 15, 219\u2013228 (1995).","journal-title":"Neuron"},{"key":"49028_CR26","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1194\/jlr.R075481","volume":"58","author":"T-PV Huynh","year":"2017","unstructured":"Huynh, T.-P. V., Davis, A. A., Ulrich, J. D. & Holtzman, D. M. Apolipoprotein E and Alzheimer\u2019s disease: the influence of apolipoprotein E on amyloid-\u03b2 and other amyloidogenic proteins: Thematic Review Series: ApoE and Lipid Homeostasis in Alzheimer\u2019s Disease. J. Lipid Res. 58, 824\u2013836 (2017).","journal-title":"J. Lipid Res."},{"key":"49028_CR27","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/ana.26351","volume":"91","author":"M Gratuze","year":"2022","unstructured":"Gratuze, M. et al. APOE Antibody Inhibits A\u03b2-Associated Tau Seeding and Spreading in a Mouse Model. Ann. Neurol. 91, 847\u2013852 (2022).","journal-title":"Ann. Neurol."},{"key":"49028_CR28","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1073\/pnas.1220484110","volume":"110","author":"PB Verghese","year":"2013","unstructured":"Verghese, P. B. et al. ApoE influences amyloid-\u03b2 (A\u03b2) clearance despite minimal apoE\/A\u03b2 association in physiological conditions. Proc. Natl Acad. Sci. 110, 1807\u20131816 (2013).","journal-title":"Proc. Natl Acad. Sci."},{"key":"49028_CR29","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1172\/JCI36663","volume":"118","author":"R Deane","year":"2008","unstructured":"Deane, R. et al. apoE isoform\u2013specific disruption of amyloid \u03b2 peptide clearance from mouse brain. J. Clin. Invest. 118, 4002\u20134013 (2008).","journal-title":"J. Clin. Invest."},{"key":"49028_CR30","doi-asserted-by":"publisher","first-page":"14745","DOI":"10.1073\/pnas.0905127106","volume":"106","author":"K Ono","year":"2009","unstructured":"Ono, K., Condron, M. M. & Teplow, D. B. Structure\u2013neurotoxicity relationships of amyloid \u03b2-protein oligomers. Proc. Natl Acad. Sci. 106, 14745\u201314750 (2009).","journal-title":"Proc. Natl Acad. Sci."},{"key":"49028_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09477-3","volume":"10","author":"S De","year":"2019","unstructured":"De, S. et al. Different soluble aggregates of A\u03b242 can give rise to cellular toxicity through different mechanisms. Nat. Commun. 10, 1541 (2019).","journal-title":"Nat. Commun."},{"key":"49028_CR32","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.40048","volume":"7","author":"X Xian","year":"2018","unstructured":"Xian, X. et al. Reversal of ApoE4-induced recycling block as a novel prevention approach for Alzheimer\u2019s disease. Elife 7, e40048 (2018).","journal-title":"Elife"},{"key":"49028_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13195-020-00585-7","volume":"12","author":"K Minta","year":"2020","unstructured":"Minta, K. et al. Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases. Alzheimers Res. Ther. 12, 19 (2020).","journal-title":"Alzheimers Res. Ther."},{"key":"49028_CR34","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nchembio.1750","volume":"11","author":"C Galvagnion","year":"2015","unstructured":"Galvagnion, C. et al. Lipid vesicles trigger \u03b1-synuclein aggregation by stimulating primary nucleation. Nat. Chem. Biol. 11, 229\u2013234 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"49028_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66373-3","volume":"10","author":"B Tahirbegi","year":"2020","unstructured":"Tahirbegi, B. et al. A Novel A\u03b240 Assembly at Physiological Concentration. Sci. Rep. 10, 9477 (2020).","journal-title":"Sci. Rep."},{"key":"49028_CR36","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/j.bbamem.2017.05.012","volume":"1859","author":"DJ Lindberg","year":"2017","unstructured":"Lindberg, D. J., Wes\u00e9n, E., Bj\u00f6rkeroth, J., Rocha, S. & Esbj\u00f6rner, E. K. Lipid membranes catalyse the fibril formation of the amyloid-\u03b2 (1\u201342) peptide through lipid-fibril interactions that reinforce secondary pathways. Biochim. Biophys. Acta - Biomembr. 1859, 1921\u20131929 (2017).","journal-title":"Biochim. Biophys. Acta - Biomembr."},{"key":"49028_CR37","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nature10016","volume":"473","author":"A Jain","year":"2011","unstructured":"Jain, A. et al. Probing cellular protein complexes using single-molecule pull-down. Nature 473, 484\u2013488 (2011).","journal-title":"Nature"},{"key":"49028_CR38","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1096\/fj.10-175976","volume":"25","author":"E Cerf","year":"2011","unstructured":"Cerf, E., Gustot, A., Goormaghtigh, E., Ruysschaert, J.-M. & Raussens, V. High ability of apolipoprotein E4 to stabilize amyloid-\u03b2 peptide oligomers, the pathological entities responsible for Alzheimer\u2019s disease. FASEB J. 25, 1585\u20131595 (2011).","journal-title":"FASEB J."},{"key":"49028_CR39","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1039\/D0SC04395H","volume":"12","author":"AM K\u00fcffner","year":"2021","unstructured":"K\u00fcffner, A. M. et al. Sequestration within biomolecular condensates inhibits A\u03b2-42 amyloid formation. Chem. Sci. 12, 4373\u20134382 (2021).","journal-title":"Chem. Sci."},{"key":"49028_CR40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00401-018-1846-7","volume":"136","author":"W Hong","year":"2018","unstructured":"Hong, W. et al. Diffusible, highly bioactive oligomers represent a critical minority of soluble A\u03b2 in Alzheimer\u2019s disease brain. Acta Neuropathol. 136, 19\u201340 (2018).","journal-title":"Acta Neuropathol."},{"key":"49028_CR41","doi-asserted-by":"publisher","first-page":"fcab147","DOI":"10.1093\/braincomms\/fcab147","volume":"3","author":"DI Sideris","year":"2021","unstructured":"Sideris, D. I. et al. Soluble amyloid beta-containing aggregates are present throughout the brain at early stages of Alzheimer\u2019s disease. Brain Commun. 3, fcab147 (2021).","journal-title":"Brain Commun."},{"key":"49028_CR42","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1093\/brain\/aws127","volume":"135","author":"RM Koffie","year":"2012","unstructured":"Koffie, R. M. et al. Apolipoprotein E4 effects in Alzheimer\u2019s disease are mediated by synaptotoxic oligomeric amyloid-\u03b2. Brain 135, 2155\u20132168 (2012).","journal-title":"Brain"},{"key":"49028_CR43","doi-asserted-by":"publisher","first-page":"15181","DOI":"10.1523\/JNEUROSCI.1542-12.2012","volume":"32","author":"T Hashimoto","year":"2012","unstructured":"Hashimoto, T. et al. Apolipoprotein E, Especially Apolipoprotein E4, Increases the Oligomerization of Amyloid \u03b2 Peptide. J. Neurosci. 32, 15181\u201315192 (2012).","journal-title":"J. Neurosci."},{"key":"49028_CR44","doi-asserted-by":"crossref","unstructured":"Stern, A. M. et al. Abundant A\u03b2 fibrils in ultracentrifugal supernatants of aqueous extracts from Alzheimer\u2019s disease brains. Neuron 111, 2012\u20132020 (2023).","DOI":"10.1016\/j.neuron.2023.04.007"},{"key":"49028_CR45","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.stemcr.2019.08.004","volume":"13","author":"H Konttinen","year":"2019","unstructured":"Konttinen, H. et al. PSEN1\u0394E9, APPswe, and APOE4 Confer Disparate Phenotypes in Human iPSC-Derived Microglia. Stem Cell Rep. 13, 669\u2013683 (2019).","journal-title":"Stem Cell Rep."},{"key":"49028_CR46","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/j.stemcr.2017.10.016","volume":"9","author":"M Oksanen","year":"2017","unstructured":"Oksanen, M. et al. PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer\u2019s Disease. Stem Cell Rep. 9, 1885\u20131897 (2017).","journal-title":"Stem Cell Rep."},{"key":"49028_CR47","doi-asserted-by":"publisher","unstructured":"Gatto, N. et al. Directly converted astrocytes retain the ageing features of the donor fibroblasts and elucidate the astrocytic contribution to human CNS health and disease. Aging Cell e13281 https:\/\/doi.org\/10.1111\/acel.13281 (2020).","DOI":"10.1111\/acel.13281"},{"key":"49028_CR48","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1073\/pnas.1314085111","volume":"111","author":"K Meyer","year":"2014","unstructured":"Meyer, K. et al. Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS. Proc. Natl Acad. Sci. 111, 829\u2013832 (2014).","journal-title":"Proc. Natl Acad. Sci."},{"key":"49028_CR49","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0896-6273(00)80187-7","volume":"17","author":"DM Paresce","year":"1996","unstructured":"Paresce, D. M., Ghosh, R. N. & Maxfield, F. R. Microglial Cells Internalize Aggregates of the Alzheimer\u2019s Disease Amyloid \u03b2-Protein;-Protein Via a Scavenger Receptor. Neuron 17, 553\u2013565 (1996).","journal-title":"Neuron"},{"key":"49028_CR50","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1523\/JNEUROSCI.3442-16.2017","volume":"37","author":"C-C Liu","year":"2017","unstructured":"Liu, C.-C. et al. Astrocytic LRP1 Mediates Brain A\u03b2 Clearance and Impacts Amyloid Deposition. J. Neurosci. 37, 4023\u20134031 (2017).","journal-title":"J. Neurosci."},{"key":"49028_CR51","doi-asserted-by":"publisher","first-page":"8354","DOI":"10.1523\/JNEUROSCI.0616-08.2008","volume":"28","author":"SE Hickman","year":"2008","unstructured":"Hickman, S. E., Allison, E. K. & El Khoury, J. Microglial Dysfunction and Defective \u03b2-Amyloid Clearance Pathways in Aging Alzheimer\u2019s Disease Mice. J. Neurosci. 28, 8354\u20138360 (2008).","journal-title":"J. Neurosci."},{"key":"49028_CR52","doi-asserted-by":"publisher","first-page":"e167","DOI":"10.1038\/cddis.2011.50","volume":"2","author":"CJ Garwood","year":"2011","unstructured":"Garwood, C. J., Pooler, A. M., Atherton, J., Hanger, D. P. & Noble, W. Astrocytes are important mediators of A\u03b2-induced neurotoxicity and tau phosphorylation in primary culture. Cell Death Dis. 2, e167\u2013e167 (2011).","journal-title":"Cell Death Dis."},{"key":"49028_CR53","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/glia.20306","volume":"53","author":"JM Craft","year":"2006","unstructured":"Craft, J. M., Watterson, D. M. & Van Eldik, L. J. Human amyloid \u03b2-induced neuroinflammation is an early event in neurodegeneration. Glia 53, 484\u2013490 (2006).","journal-title":"Glia"},{"key":"49028_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-019-0777-4","volume":"7","author":"S De","year":"2019","unstructured":"De, S. et al. Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer\u2019s disease progression. Acta Neuropathol. Commun. 7, 1 (2019).","journal-title":"Acta Neuropathol. Commun."},{"key":"49028_CR55","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/s41594-020-0471-z","volume":"10","author":"P Flagmeier","year":"2020","unstructured":"Flagmeier, P. et al. Direct measurement of lipid membrane disruption connects kinetics and toxicity of A\u03b242 aggregation. Nat. Struct. Mol. Biol. 10, 886\u2013891 (2020).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"49028_CR56","doi-asserted-by":"publisher","first-page":"7750","DOI":"10.1002\/anie.201700966","volume":"56","author":"P Flagmeier","year":"2017","unstructured":"Flagmeier, P. et al. Ultrasensitive measurement of Ca2+ influx into lipid vesicles induced by protein aggregates. Angew. Chem. Int. Ed. 56, 7750\u20137754 (2017).","journal-title":"Angew. Chem. Int. Ed."},{"key":"49028_CR57","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1016\/j.celrep.2017.11.057","volume":"21","author":"A Drews","year":"2017","unstructured":"Drews, A. et al. Inhibiting the Ca2+ influx induced by human CSF. Cell Rep. 21, 3310\u20133316 (2017).","journal-title":"Cell Rep."},{"key":"49028_CR58","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1126\/science.274.5284.99","volume":"274","author":"K Hsiao","year":"1996","unstructured":"Hsiao, K. et al. Correlative Memory Deficits, A\u03b2 Elevation, and Amyloid Plaques in Transgenic Mice. Science. 274, 99\u2013103 (1996).","journal-title":"Science."},{"key":"49028_CR59","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","volume":"46","author":"CA McLean","year":"1999","unstructured":"McLean, C. A. et al. Soluble pool of A\u03b2 amyloid as a determinant of severity of neurodegeneration in Alzheimer\u2019s disease. Ann. Neurol. 46, 860\u2013866 (1999).","journal-title":"Ann. Neurol."},{"key":"49028_CR60","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0006-8993(91)91092-F","volume":"541","author":"Y Namba","year":"1991","unstructured":"Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E. & Ikeda, K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer\u2019s disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541, 163\u2013166 (1991).","journal-title":"Brain Res."},{"key":"49028_CR61","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/BF03402018","volume":"8","author":"Z Zhou","year":"2002","unstructured":"Zhou, Z., Relkin, N., Ghiso, J., Smith, J. D. & Gandy, S. Human Cerebrospinal Fluid Apolipoprotein E Isoforms are Apparently Inefficient at Complexing with Synthetic Alzheimer\u2019s Amyloid-\u03b2 Peptide (A\u00df1\u221240) in vitro. Mol. Med. 8, 376\u2013381 (2002).","journal-title":"Mol. Med."},{"key":"49028_CR62","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.ajpath.2019.04.010","volume":"189","author":"T Bilousova","year":"2019","unstructured":"Bilousova, T. et al. Apolipoprotein E\/Amyloid-\u03b2 Complex Accumulates in Alzheimer Disease Cortical Synapses via Apolipoprotein E Receptors and Is Enhanced by APOE4. Am. J. Pathol. 189, 1621\u20131636 (2019).","journal-title":"Am. J. Pathol."},{"key":"49028_CR63","doi-asserted-by":"publisher","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","volume":"90","author":"DE Schmechel","year":"1993","unstructured":"Schmechel, D. E. et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl Acad. Sci. 90, 9649\u20139653 (1993).","journal-title":"Proc. Natl Acad. Sci."},{"key":"49028_CR64","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13024-016-0099-y","volume":"11","author":"Y Fu","year":"2016","unstructured":"Fu, Y. et al. Apolipoprotein E lipoprotein particles inhibit amyloid-\u03b2 uptake through cell surface heparan sulphate proteoglycan. Mol. Neurodegener. 11, 37 (2016).","journal-title":"Mol. Neurodegener."},{"key":"49028_CR65","doi-asserted-by":"publisher","first-page":"4252","DOI":"10.1523\/JNEUROSCI.5572-08.2009","volume":"29","author":"S Mandrekar","year":"2009","unstructured":"Mandrekar, S. et al. Microglia Mediate the Clearance of Soluble A\u03b2 through Fluid Phase Macropinocytosis. J. Neurosci. 29, 4252\u20134262 (2009).","journal-title":"J. Neurosci."},{"key":"49028_CR66","unstructured":"Wang, W.-Y., Tan, M.-S., Yu, J.-T. & Tan, L. Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease. Ann. Transl. Med. 3, 136\u2013150 (2015)."},{"key":"49028_CR67","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1750-3639.1998.tb00136.x","volume":"8","author":"WST Griffin","year":"1998","unstructured":"Griffin, W. S. T. et al. Glial-Neuronal Interactions in Alzheimer\u2019s Disease: The Potential Role of a \u2018Cytokine Cycle\u2019 in Disease Progression. Brain Pathol. 8, 65\u201372 (1998).","journal-title":"Brain Pathol."},{"key":"49028_CR68","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1001\/jamaneurol.2013.396","volume":"70","author":"AJ Hanson","year":"2013","unstructured":"Hanson, A. J. et al. Effect of Apolipoprotein E Genotype and Diet on Apolipoprotein E Lipidation and Amyloid Peptides: Randomized Clinical TrialApolipoprotein E Lipidation and Amyloid Peptides. JAMA Neurol. 70, 972\u2013980 (2013).","journal-title":"JAMA Neurol."},{"key":"49028_CR69","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13024-015-0001-3","volume":"10","author":"J Hu","year":"2015","unstructured":"Hu, J. et al. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and A\u03b2 metabolism in apoE4-targeted replacement mice. Mol. Neurodegener. 10, 6 (2015).","journal-title":"Mol. Neurodegener."},{"key":"49028_CR70","doi-asserted-by":"publisher","first-page":"43236","DOI":"10.1074\/jbc.M508780200","volume":"280","author":"SE Wahrle","year":"2005","unstructured":"Wahrle, S. E. et al. Deletion of Abca1 Increases A\u03b2 Deposition in the PDAPP Transgenic Mouse Model of Alzheimer Disease. J. Biol. Chem. 280, 43236\u201343242 (2005).","journal-title":"J. Biol. Chem."},{"key":"49028_CR71","doi-asserted-by":"publisher","first-page":"43224","DOI":"10.1074\/jbc.M504513200","volume":"280","author":"R Koldamova","year":"2005","unstructured":"Koldamova, R., Staufenbiel, M. & Lefterov, I. Lack of ABCA1 Considerably Decreases Brain ApoE Level and Increases Amyloid Deposition in APP23 Mice. J. Biol. Chem. 280, 43224\u201343235 (2005).","journal-title":"J. Biol. Chem."},{"key":"49028_CR72","first-page":"671","volume":"118","author":"SE Wahrle","year":"2008","unstructured":"Wahrle, S. E. et al. Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. J. Clin. Invest. 118, 671\u2013682 (2008).","journal-title":"J. Clin. Invest."},{"key":"49028_CR73","doi-asserted-by":"publisher","first-page":"6292","DOI":"10.1073\/pnas.1705080114","volume":"114","author":"C Frieden","year":"2017","unstructured":"Frieden, C., Wang, H. & Ho, C. M. W. A mechanism for lipid binding to apoE and the role of intrinsically disordered regions coupled to domain\u2013domain interactions. Proc. Natl Acad. Sci. 114, 6292\u20136297 (2017).","journal-title":"Proc. Natl Acad. Sci."},{"key":"49028_CR74","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.neuron.2020.10.008","volume":"109","author":"Y Chen","year":"2021","unstructured":"Chen, Y., Strickland, M. R., Soranno, A. & Holtzman, D. M. Apolipoprotein E: Structural Insights and Links to Alzheimer Disease Pathogenesis. Neuron 109, 205\u2013221 (2021).","journal-title":"Neuron"},{"key":"49028_CR75","doi-asserted-by":"publisher","first-page":"a006312","DOI":"10.1101\/cshperspect.a006312","volume":"2","author":"DM Holtzman","year":"2012","unstructured":"Holtzman, D. M., Herz, J. & Bu, G. Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer Disease. Cold Spring Harb. Perspect. Med. 2, a006312 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"49028_CR76","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","volume":"91","author":"FL Yeh","year":"2016","unstructured":"Yeh, F. L., Wang, Y., Tom, I., Gonzalez, L. C. & Sheng, M. TREM2 Binds to Apolipoproteins, Including APOE and CLU\/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia. Neuron 91, 328\u2013340 (2016).","journal-title":"Neuron"},{"key":"49028_CR77","doi-asserted-by":"publisher","first-page":"108224","DOI":"10.1016\/j.celrep.2020.108224","volume":"33","author":"P Narayan","year":"2020","unstructured":"Narayan, P. et al. PICALM Rescues Endocytic Defects Caused by the Alzheimer\u2019s Disease Risk Factor APOE4. Cell Rep. 33, 108224 (2020).","journal-title":"Cell Rep."},{"key":"49028_CR78","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/1873-3468.13428","volume":"593","author":"E Hubin","year":"2019","unstructured":"Hubin, E., Verghese, P. B., van Nuland, N. & Broersen, K. Apolipoprotein E associated with reconstituted high-density lipoprotein-like particles is protected from aggregation. FEBS Lett. 593, 1144\u20131153 (2019).","journal-title":"FEBS Lett."},{"key":"49028_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14440\/jbm.2014.36","volume":"1","author":"AD Edelstein","year":"2014","unstructured":"Edelstein, A. D. et al. Advanced methods of microscope control using \u03bcManager software. J. Biol. Methods 1, 1\u201310 (2014).","journal-title":"J. Biol. Methods"},{"key":"49028_CR80","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-49028-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-49028-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-49028-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T15:01:45Z","timestamp":1717254105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-49028-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,1]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["49028"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-49028-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2208663\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,1]]},"assertion":[{"value":"28 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.M.H. is an inventor on a patent licensed by Washington University to NextCure on anti-apoE antibodies. D.M.H. co-founded and is on the scientific advisory board of C2N Diagnostics, DenaliGenentech, and Cajal Neuroscience. D.M.H. consults for Asteroid. The lab of D.M.H. receives research grants from the National Institutes of Health, Cure Alzheimer\u2019s Fund, Tau Consortium, the JPB Foundation, Good Ventures, the Rainwater Foundation, NextCure, Eli Lilly, and Ionis. D.C.C. and P.T. hold stock in AstraZeneca. All the other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4695"}}